New approach for treating recurrent prostate cancer on the horizon

A new study shows that an alpha-particle emitting radiopeptide—radioactive material bound to a synthetic peptide, a component of protein—is effective for treating prostate cancer in mice, according to researchers. The results could eventually result in a significant breakthrough in prostate cancer treatment, especially for patients whose cancer recurs after the prostate is removed.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news164292070.html">New approach for treating recurrent prostate cancer on the horizon</a></p> <p>A new study shows that an alpha-particle emitting radiopeptide—radioactive material bound to a synthetic peptide, a component of protein—is effective for treating prostate cancer in mice, according to researchers. The results could eventually result in a significant breakthrough in prostate cancer treatment, especially for patients whose cancer recurs after the prostate is removed.</p>